Philip Kim

Company: University of Toronto
Job title: Professor & Principal Investigator
Seminars:
Merging Antibody Developability with De Novo Design 2:15 pm
Exploring the interplay between structure and sequence-based biologics design Implementing machine learning tools for structure-based de novo design Highlighting the data challenges that limit thisRead more
day: Day Two